<DOC>
	<DOCNO>NCT00990756</DOCNO>
	<brief_summary>The purpose study investigate safety toleration multiple inhaled dos well time course PF-03526299 concentration blood follow dose dry powder inhaler .</brief_summary>
	<brief_title>A Phase 1 Study To Evaluate The Safety And Tolerability Of Different Doses Of PF-03526299 In Healthy Adult Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy male subject females nonchildbearing potential age 21 55 year . Body Mass Index ( BMI ) 17.5 30.5 kg/m^2 ; total body weight &gt; 50 kg ( 110 lb ) . Subjects normal chest Xray previous 6 month prior Screening Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) . A positive urine drug screen . History regular alcohol consumption exceed 21 drinks/week male 14 drinks/week female .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2010</verification_date>
</DOC>